Clinical trials: sponsored by Linkoeping University
Malignant Melanoma
Diagnostic Precision of the AI Tool Dermalyzer to Identify Malignant Melanomas in Subjects Seeking Primary Care for Melanoma-suspected Cutaneous Lesions
Dermalyzer is a device intended to be used as a decision support system for assessing cutaneous lesions suspected of being melanomas.
- Trial name
- AI-DSMM (NCT05172232)
- Testing
- Dermalyzer
- Where
- 3 sites in Sweden
- Volunteers
- 231 people
- Sponsor
- Linkoeping University